| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000041954 |
| Receipt No. | R000047886 |
| Scientific Title | Study on the absorption and urinary excretion of minerals from vegetable juices |
| Date of disclosure of the study information | 2020/10/01 |
| Last modified on | 2021/09/29 (Ver. 2) |
| Basic information | ||
| Public title | Study on the absorption and urinary excretion of minerals from vegetable juices | |
| Acronym | Study on the absorption and urinary excretion of minerals from vegetable juices | |
| Scientific Title | Study on the absorption and urinary excretion of minerals from vegetable juices | |
| Scientific Title:Acronym | Study on the absorption and urinary excretion of minerals from vegetable juices | |
| Region |
|
|
| Condition | |||
| Condition | healthy | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | Understanding the effect of vegetable juice intake on the urinary sodium/potassium ratio |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | urinary sodium/potassium ratio |
| Key secondary outcomes | Salt intake estimates |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Cross-over |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -no one is blinded |
| Control | Dose comparison |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 3 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | Intake of tomato-containing vegetable juice (7 days) > Washout (3 days) > Intake of concentrated vegetable juice (7 days) > Washout (3 days) > Intake of vegetable juice (7 days) | |
| Interventions/Control_2 | Intake of concentrated vegetable juice (7 days) > Washout (3 days) > Intake of vegetable juice (7 days) > Washout (3 days) > Intake of tomato-containing vegetable juice (7 days) | |
| Interventions/Control_3 | Intake of vegetable juice (7 days) > Washout (3 days) > Intake of tomato-containing vegetable juice (7 days) > Washout (3 days) >Intake of concentrated vegetable juice (7 days) | |
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1) Healthy Japanese men or postmenopausal Japanese women, the ages of more than 20 years old and less than 65 years old
2) Subjects who can fill out a web survey with a smartphone or iPhone 3) Subjects who get the sufficient explanation of the purpose and content of this study, have the ability to consent, voluntarily apply with the sufficient understanding, and approve of the participation in the document |
|||
| Key exclusion criteria | 1) Subjects with severe hepatic, renal, cardiac, pulmonary, gastrointestinal, hematologic, endocrine and metabolic diseases/disorders
2) Subjects who have diseases/disorders with continuous medical treatment or have medical history of severe diseases/disorders needed medical treatment 3) Subjects who receive medical treatment for digestive diseases/disorders which affect this study, or have surgical history of digestive system (except appendectomy) 4) Subjects with food allergies to ingredients in vegetable juices used in this study 5) Subjects who have received dietary guidance on potassium from a doctor or nutritionist 6) Subjects who habitually drink vegetable juices at least three times a week 7) Subjects who have been watching salt reduction and prefer a lighter taste 8) Any candidate considered to be unsuitable for enrollment based on his/her answers of lifestyle questionnaire 9) Subjects who had participated in other clinical trials including drug and food within 1 month 10) Subjects who are judged as inappropriate by investigators |
|||
| Target sample size | 24 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | KAGOME CO., LTD. | ||||||
| Division name | Innovation Division | ||||||
| Zip code | 329-2762 | ||||||
| Address | 17 Nishitomiyama, Nasushiobara-shi, Tochigi, Japan | ||||||
| TEL | 0287-36-2935 | ||||||
| Yusuke_Ushida@kagome.co.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Leverage Brain Inc. | ||||||
| Division name | Clinical Trial Department | ||||||
| Zip code | 105-0004 | ||||||
| Address | 2-16-1 Shinbashi Minato-ku, Tokyo, Japan | ||||||
| TEL | 080-7290-0404 | ||||||
| Homepage URL | |||||||
| imai@levbrain.com | |||||||
| Sponsor | |
| Institute | KAGOME CO., LTD |
| Institute | |
| Department | |
| Funding Source | |
| Organization | KAGOME CO., LTD |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Japan Conference of Clinical Research (JCCR) |
| Address | 1-13-23 Minamiikebukuro Toshima-ku, Tokyo, Japan |
| Tel | 03-6868-7022 |
| jccr-info@cts-smo.com | |
| Secondary IDs | |
| Secondary IDs | YES |
| Study ID_1 | 2020-R12 |
| Org. issuing International ID_1 | The Ethics Committee of KAGOME CO., LTD. |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047886 |